Wireless Cardiac Monitoring Technologies Advance Arrhythmia Detection and Remote Care

Introduction

Cardiac rhythm abnormalities can occur intermittently, making them difficult to identify during a routine ECG examination. Wireless cardiac monitoring allows clinicians to record heart activity while patients continue their daily activities.

Wearable ECG patches, mobile cardiac telemetry and remote monitoring platforms are extending cardiac assessment beyond hospitals. These technologies also create opportunities for medical device manufacturers, digital health companies and remote monitoring providers.

Explore cardiac monitoring company intelligence, technology developments and competitive opportunities with Towards Healthcare: 

Industry Snapshot

The US FDA recognises wearable and connected medical devices that collect health information outside traditional clinical settings. These include ECG monitoring technologies designed for ambulatory use.

In 2026, updated Medicare coverage policies addressed several temporary ambulatory cardiac monitoring technologies, including ECG patches, Holter monitors, event monitors and mobile cardiac telemetry. Coverage depends on the applicable regional policy, clinical indication and medical-necessity requirements.

These developments highlight the importance of remote cardiac monitoring in clinical assessment. However, ambulatory monitors are diagnostic tools, not guaranteed emergency-warning systems.

Key Technology Segments

1. Wearable ECG Patches and Holter Monitors

Wearable ECG patches record the heart's electrical activity during everyday activities. Depending on the device, monitoring can continue for several days or weeks.

Holter monitors provide continuous ECG recording over a prescribed period, while extended-wear patches support longer observation. These devices help clinicians investigate intermittent palpitations, dizziness and suspected arrhythmias.

2. Mobile Cardiac Outpatient Telemetry

Mobile cardiac outpatient telemetry (MCOT) continuously analyses ECG data and can transmit detected events to a monitoring centre.

This technology supports remote review and clinical notification when relevant abnormalities are detected. Reliable connectivity, trained monitoring staff and appropriate escalation procedures are essential.

3. Wireless Event Monitors and Loop Recorders

Event monitors capture cardiac activity when patients experience symptoms or when a device identifies a specific rhythm event.

External loop recorders retain ECG information around an event, while implantable loop recorders provide longer-term monitoring for selected patients. These technologies help investigate infrequent symptoms that may not appear during routine examinations.

4. Remote Monitoring Platforms and ECG Analytics

Remote monitoring platforms collect, transmit and organise ECG data for clinical review. Analytical software can identify potential rhythm abnormalities and prioritise recordings for assessment.

Integration with electronic health records, clinical dashboards and cardiology workflows is becoming an important consideration for healthcare providers.

Company Landscape

Key Company Developments

iRhythm Technologies: Its Zio monitoring portfolio supports extended ambulatory ECG recording. The combination of wearable devices, algorithm-based analysis and clinical review supports the identification of cardiac rhythm abnormalities.

Philips: Its cardiac monitoring portfolio includes Holter monitoring, extended-wear monitoring and mobile cardiac telemetry. The company also provides remote monitoring services that support ECG analysis and clinical reporting.

Boston Scientific: Its BodyGuardian product family provides remote cardiac monitoring solutions. The portfolio includes wearable devices designed to support different ambulatory monitoring requirements.

Baxter: Through its BardyDx portfolio, Baxter offers the Carnation Ambulatory Monitor (CAM), a wearable ECG patch designed for ambulatory cardiac monitoring. The technology supports extended ECG recording and clinical assessment.

Market Gaps

1. Patient adherence and comfort: Skin irritation, adhesive sensitivity and discomfort can affect consistent device use during extended monitoring periods.

2. False alerts and data overload: Continuous ECG recording generates large datasets. Excessive alerts can increase the workload for technicians and clinicians, making accurate detection and prioritisation important.

3. Connectivity and integration: Data transmission interruptions and incompatible clinical systems can delay access to ECG results. Healthcare providers need reliable connectivity and effective electronic health record integration.

4. Reimbursement and access: Coverage requirements vary by region, monitoring technology and clinical indication. Differences in reimbursement can influence purchasing decisions and patient access.

5. Clinical response management: Monitoring services require clear processes for reviewing abnormal recordings, notifying clinicians and escalating urgent findings. Technology alone cannot replace clinical oversight.

Business Opportunities

AI-Assisted ECG Analysis

Manufacturers can develop algorithms that identify potential arrhythmias, classify ECG patterns and prioritise clinically relevant recordings.

The opportunity lies in reducing unnecessary review workloads while maintaining reliable analytical performance. Clinical validation, algorithm transparency and regulatory compliance will remain important.

Smaller and More Comfortable Wearable Devices

Lightweight patches, skin-friendly adhesives, flexible sensors and longer battery life can improve the patient experience.

Manufacturers that address comfort and ease of use may strengthen their position in extended monitoring applications.

Integrated Remote Monitoring Platforms

Connected platforms combining wearable devices, ECG analytics, clinical dashboards and electronic health records can simplify data management for hospitals and cardiology practices.

Interoperability and cybersecurity should remain central to product development.

Remote Cardiac Monitoring Services

Healthcare technology companies can expand services that combine device distribution, patient onboarding, continuous data review and clinical reporting.

These service models can help cardiology practices manage remote monitoring workflows more efficiently.

Specialised Monitoring Solutions

There are opportunities to develop monitoring pathways for selected patient groups, including patients requiring post-ablation follow-up, those with suspected intermittent arrhythmias and patients undergoing assessment after cryptogenic stroke.

Manufacturers can differentiate their offerings through clinical workflow integration and application-specific device designs.

What Should Hospitals Evaluate Before Selecting a Cardiac Monitoring System?

Hospitals and cardiology practices should assess:

• Recording capability: Continuous, intermittent or event-triggered ECG monitoring.

• Monitoring duration: Wear time, battery performance and data storage.

• Patient comfort: Device size, adhesive quality and skin compatibility.

• Analytical performance: Rhythm detection accuracy, false-alert rates and clinical validation.

• Connectivity: Data transmission reliability and compatibility with existing systems.

• Clinical support: Availability of trained technicians, reporting services and escalation protocols.

• Commercial viability: Device costs, consumables, reimbursement and service agreements.

The selected technology should match the patient's clinical requirements and the level of monitoring needed.

How Towards Healthcare Supports Industry Decision-Makers

Towards Healthcare provides strategic intelligence to help medical device manufacturers, healthcare organisations and investors assess cardiac monitoring technologies and competitive opportunities.

Our capabilities include:

• Complete Master Datasets: Company, product and technology intelligence.

• Competitive Quadrants: Assessment of cardiac monitoring manufacturers and product capabilities.

• Customized Dashboards: Structured intelligence on product developments and company activities.

• Buyer Identification: Identification of relevant hospitals, cardiology practices and procurement stakeholders.

• GTM Strategy: Assessment of regional opportunities, target customers and commercial partnerships.

Conclusion

Wireless cardiac monitoring is extending ECG assessment into patients' daily lives. Wearable patches, mobile telemetry and remote analysis platforms offer clinicians additional ways to investigate intermittent rhythm abnormalities and support follow-up care.

For manufacturers, commercial opportunities include more comfortable devices, validated ECG analytics, connected monitoring platforms and integrated clinical services. Reliable data transmission, clinical oversight and appropriate patient selection remain essential for successful adoption.

About Us

Healthcare WebWire is a part of Towards Healthcare, which is a healthcare intelligence and market research company specializing in market intelligence, competitive intelligence, customer intelligence, pipeline intelligence, market sizing and commercial strategy across pharmaceutical, biotechnology, medical device and healthcare markets.

Contact us for quick meeting, customized data, free samples or further enquiry at [email protected]

Europe Region - +44 778 256 0738

North America Region - +1 8044 4193 44

APAC Region: +91 9356 9282 04

Visit Our Website: https://www.towardshealthcare.com

Find us on social platforms: LinkedIn | Twitter | Instagram